CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score -3.58: distress zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
528.00MUSDvs all stocks (USD)
Revenue (TTM)
221.55MUSDvs all stocks (USD)
Profit Margin
-3.06%vs Medical Devices peers
Beta
1.80xvs all stocks
52-Week Change
72.37%vs all stocks
Market Capitalization
528.00MUSDvs all stocks (USD)
Enterprise Value
549.22MUSDvs all stocks (USD)
Forward P/E
-524.00xvs Medical Devices peers
Price to Sales (TTM)
2.38xvs Medical Devices peers
Price to Book (MRQ)
7.53xvs Medical Devices peers
Enterprise to Revenue
2.48xvs Medical Devices peers
Gross Margin
51.41%vs Medical Devices peers
Profit Margin
-3.06%vs Medical Devices peers
Operating Margin
-3.23%vs Medical Devices peers
Return on Assets (TTM)
-0.48%vs Medical Devices peers
Return on Equity (TTM)
-10.77%vs Medical Devices peers
Revenue (TTM)
221.55MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.14USDUpdated Sep 27, 2026Quarterly Revenue Growth
9.50%vs Medical Devices peers
Gross Profit (TTM)
115.31MUSDvs all stocks (USD)
EBITDA (TTM)
66.00KUSDvs all stocks (USD)
Net Income (TTM)
-6.78MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
9.53%vs Medical Devices peers
Operating Cash Flow (TTM)
2.42MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
875.25KUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
741.00KUSDFY2025 · Dec 31, 2025Revenue
206.13MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
93.84MUSDFY2025 · Dec 31, 2025Gross Profit
112.29MUSDFY2025 · Dec 31, 2025Operating Income
-8.68MUSDvs all stocks (USD)
Pre-tax Income
-15.28MUSDFY2025 · Dec 31, 2025Income Tax Expense
354.00KUSDFY2025 · Dec 31, 2025Net Income
-15.64MUSDFY2025 · Dec 31, 2025EBIT
-6.94MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-4.24MUSDFY2025 · Dec 31, 2025Research & Development
67.72MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
80.91MUSDFY2025 · Dec 31, 2025Other Operating Expenses
-27.66MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
8.34MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0800USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800USDFY2025 · Dec 31, 2025Basic Shares Outstanding
190.59MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
190.59MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-15.64MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
10.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
2.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
20.60MUSDFY2025 · Dec 31, 2025Income Tax Paid
301.00KUSDFY2025 · Dec 31, 2025Interest Paid
8.52MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-15.64MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.43MUSDFY2025 · Dec 31, 2025Stock-based Compensation
22.87MUSDFY2025 · Dec 31, 2025Other Non-cash Items
2.93MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-396.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
5.72MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-14.81MUSDFY2025 · Dec 31, 2025Purchase of Investments
-42.78MUSDFY2025 · Dec 31, 2025Sale of Investments
40.34MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.44MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-329.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-35.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-364.00KUSDFY2025 · Dec 31, 2025Shares Outstanding
201.46MSharesUpdated Sep 27, 2026Float Shares
195.35MSharesUpdated Sep 27, 2026Shares Short
17.99MSharesUpdated Sep 27, 2026Short Ratio
12.36daysvs all stocks
Short % of Shares Outstanding
9.19%vs all stocks
% Held by Insiders
3.61%vs all stocks
% Held by Institutions
73.44%vs all stocks
Total Cash (MRQ)
56.26MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.2790USDUpdated Sep 27, 2026Total Debt (MRQ)
76.80MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.09xvs Medical Devices peers
Current Ratio (MRQ)
1.83xvs Medical Devices peers
Book Value per Share (MRQ)
0.3480USDUpdated Sep 27, 2026Total Assets
221.86MUSDvs all stocks (USD)
Total Current Assets
174.38MUSDFY2025 · Dec 31, 2025Total Liabilities
156.89MUSDFY2025 · Dec 31, 2025Total Non-current Assets
47.48MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
56.09MUSDFY2025 · Dec 31, 2025Total Current Liabilities
100.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
19.96MUSDFY2025 · Dec 31, 2025Other Short-term Investments
62.92MUSDFY2025 · Dec 31, 2025Accounts Receivable
30.37MUSDFY2025 · Dec 31, 2025Inventory
56.10MUSDFY2025 · Dec 31, 2025Accounts Payable
28.01MUSDFY2025 · Dec 31, 2025Short-term Debt
46.25MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.27MUSDFY2025 · Dec 31, 2025Long-term Debt
50.70MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
5.39MUSDFY2025 · Dec 31, 2025Common Stock (Book)
192.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.08BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
64.97MUSDvs all stocks (USD)
52-Week Low
1.38USDUpdated Sep 27, 202652-Week High
3.47USDUpdated Sep 27, 202652-Week Change
72.37%vs all stocks
Beta
1.80xvs all stocks
50-Day MA
2.69USDUpdated Sep 27, 2026200-Day MA
2.42USDUpdated Sep 27, 2026Avg 10-Day Volume
2.17MSharesUpdated Sep 27, 2026Avg 30-Day Volume
1.75MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-0.0300USDUpdated Sep 27, 2026Other Income / Expense
1.74MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.51Profit Margin: -0.03
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.83Altman Z-Score: -3.58
Financial Health
Altman Z-Score -3.58: distress zoneCritical
Altman Z-Score: -3.58
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Senseonics Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
LivsMed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guangdong Lifestrong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Easydiagnosis Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pulike Biological Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Crescent Biopharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuzhou Special Paper Group Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Sunwoda Electronic Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Wonders Information Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators